Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mizuho Securities USA
Biotech
Sarepta rewarded by Wall Street for FDA committee shocker
Sarepta's shares skyrocketed Monday after FDA advisers endorsed the risk-benefit profile of the company's DMD gene therapy.
Max Bayer
May 15, 2023 11:05am
Selecta lays off 25% as unpartnered gene therapies dropped
May 5, 2023 10:45am
After a year of 'right sizing,' will biotech rebloom in 2023?
Dec 22, 2022 5:00am